论文部分内容阅读
肾综合征出血热(HFRS)早期患者的治疗,自推广应用联合抗过敏疗法以来,使病死率下降到1％以下,但对该病的中晚期(发热期后各期)患者尚无有效疗法,病死率较高,近5年来,我院采用联合抗过敏加用新鲜全血治疗HFRS中晚期患者,临床观察91例,疗效满意。结果报道如下: 1 临床资料 1.1 一般资料 选用1993年11月～1997年2月确诊的HFRS中晚期中重型以上的住院患者。诊断、分型标准按1988年HFRS防治方案。治疗组91例,其中男63例,女28例,危重型26例,发病年龄14～80(39.14
The treatment of patients with early stage renal syndrome hemorrhagic fever (HFRS) has reduced the case fatality rate to less than 1% since the introduction of the combination anti-allergy therapy, but there is no effective treatment for patients with advanced to advanced stage (post-war period) disease , High mortality, the past 5 years, our hospital combined anti-allergy plus fresh whole blood treatment of advanced HFRS patients, clinical observation of 91 cases, the effect is satisfactory. The results are reported as follows: 1 Clinical data 1.1 General information selected in November 1993 ~ February 1997 confirmed HFRS in the medium and advanced patients with medium and large in the hospital. Diagnosis, classification criteria according to the 1988 HFRS prevention and treatment programs. Treatment group of 91 cases, 63 males and 28 females, 26 cases of critical type, the age of onset 14 ~ 80 (39.14